Fig. 5
- ID
- ZDB-IMAGE-111215-21
- Publication
- Nguyen et al., 2011 - A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish
- All Figures
- Figures for Nguyen et al., 2011
Fig. 5 Activation of the Wnt–β-catenin pathway during krasV12 liver tumorigenesis. Representative immunohistochemical liver sections from WT zebrafish as the control and krasV12 transgenic fish with liver hyperplasia and carcinoma are shown. (A) Immunohistochemistry for β-catenin showing an increasing nuclear localization of β-catenin during HCC progression. (B) Immunohistochemistry for E-cadherin showing loss of membranous E-cadherin expression during tumor growth. (C) Immunohistochemistry for Ki67 showing a high expression level of Ki67 in cell nuclei, which increased from hyperplasia to carcinoma.